Pfizer

Three strategies for managing loss of exclusivity successfully
Pharmaforum
Thu, 08/29/19 - 11:49 pm
market exclusivity
patents
Humalog
Viagra
Eli Lilly
Pfizer
Towards patient centricity: Pfizer
Pharmaforum
Thu, 08/29/19 - 10:10 am
Pfizer
patients
patient centricity
FTC Issues Civil Investigative Demand to Johnson & Johnson Regarding Remicade
Big Molecule Watch
Sun, 08/25/19 - 05:02 pm
Remicade
JNJ
Pfizer
antitrust
Walgreens
Kroger
Pfizer, Astellas rocket toward broader Xtandi use with FDA 'priority' tag
Fierce Pharma
Thu, 08/22/19 - 11:56 am
Pfizer
Astellas
Xtandi
prostate cancer
FDA
priority review
Pfizer injects $500M more into gene therapy manufacturing
Biopharma Dive
Wed, 08/21/19 - 11:44 pm
Pfizer
gene therapy
drug manufacturing
North Carolina
Lyrica looking grim: Pfizer blockbuster's market share crumbles under generic attack
Fierce Pharma
Mon, 08/19/19 - 11:46 pm
Pfizer
patents
Lyrica
generics
Is Pfizer's established drugs' decline in China the ‘canary in the coalmine?’
Fierce Pharma
Mon, 08/19/19 - 11:55 am
Pfizer
Upjohn
China
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
Xconomy
Sat, 08/17/19 - 01:28 pm
IPOs
SpringWorks Therapeutics
Pfizer
Satsuma Pharmaceuticals
5 Biggest New Drugs Approved in 2019 So Far
Motley Fool
Tue, 08/13/19 - 11:43 am
drug approvals
FDA
AbbVie
JNJ
Novartis
Pfizer
Skyrizi
psoriasis
Vyndaqel
Zolgensma
SMA
Mayzent
multiple sclerosis
Balversa
metastatic bladder cancer
Hospitals rationing immune disorder drug
Beckers Hospital Review
Fri, 08/9/19 - 07:37 pm
Human Immune Globulin Infusion
drug shortages
Pfizer
Takeda
GlycoMimetics shares crash after Pfizer team dismisses their lead drug as a PhIII failure
Endpoints
Mon, 08/5/19 - 12:03 am
Pfizer
GlycoMimetics
sickle cell disease
Rivipansel
These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024
Yahoo/Motley Fool
Sun, 08/4/19 - 01:02 pm
Merck
Keytruda
AbbVie
Humira
Pfizer
Bristol-Myers Squibb
Eliquis
JNJ
Imbruvica
Mylan-Upjohn Merger Leaves Analysts Skeptical
Xtalks
Sat, 08/3/19 - 02:38 pm
analysts
M&A
Mylan
Pfizer
Upjohn
After Mylan Gets Acquired, Could Teva Be Next?
Yahoo/Guru Focus
Sat, 08/3/19 - 12:57 pm
Pfizer
Upjohn
Mylan
Teva Pharmaceutical
M&A
Pfizer may send EpiPen manufacturing to generics spinoff
Biopharma Dive
Fri, 08/2/19 - 12:18 am
Pfizer
Mylan
M&A
Meridian Medical Technologies
EpiPens
drug shortages
GSK split edges closer as OTC joint venture deal with Pfizer closes
Pharmaforum
Thu, 08/1/19 - 11:48 am
GSK
Pfizer
OTC
M&A
RegenxBio and Pfizer Partner on Gene Therapy for Friedreich's Ataxia
BioSpace
Wed, 07/31/19 - 11:50 pm
Regenxbio
Pfizer
gene therapy
Friedreich's Ataxia
Pfizer points to newer meds—including Ibrance—as post-Upjohn cash engines
Fierce Pharma
Tue, 07/30/19 - 11:00 pm
Pfizer
Upjohn
Ibrance
Plagued by production issues, Pfizer aims to shift EpiPen work to Mylan-Upjohn merger
Fierce Pharma
Tue, 07/30/19 - 04:26 pm
Mylan
Pfizer
Upjohn
EpiPens
drug shortages
How Mylan ended as a junior partner in its Pfizer deal
Biopharma Dive
Tue, 07/30/19 - 04:20 pm
Mylan
Pfizer
Perrigo
Teva Pharmaceutical
M&A

Pages